
- Volume 39, Issue 9 Psychedelics Supplement
Numinus Resources
Numinus' Chief Clinical Officer shares resources about the potential use of ketamine in psychiatry.
Sponsored
PARTNER PERSPECTIVES
Q&A With Dr. Reid Robison
Chief Clinical Officer, Numinus
To read the article, please see the September Supplement to Psychiatric TimesTM.
RESOURCES
Bandeira ID, Lins-Silva DH, Cavenaghi VB, et al.
Berman RM, Cappiello A, Anand A, et al.
Feder A, Parides MK, Murrough JW, et al.
Ito W, Erisir A, Morozov A.
Mathew SJ, Murrough JW, aan het Rot M, Collins KA, Reich DL, Charney DS.
Newport DJ, Carpenter LL, McDonald WM, et al.
Niciu MJ, Ionescu DF, Richards EM, Zarate CA Jr.
Rodriguez CI, Kegeles LS, Levinson A, et al.
Zarate CA Jr, Singh JB, Carlson PJ, et al.
Articles in this issue
about 3 years ago
Effects of LSD and Psilocybin in Healthy Participantsabout 3 years ago
Challenging the Status Quo of the Challenge to the Status QuoNewsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.